Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Didronel PMO now available for expanded use in the U.K.

July 9, 1997

Lilly reports new salt of PKC inhibitor with improved pharmaceutical properties

July 9, 1997

SmithKline Beecham focuses on hemoregulatory compounds

July 9, 1997

Senetek seeks Danish approval of erectile dysfunction therapy

July 8, 1997

Bioisosteres of sulfonylureas prepared by Belgian investigators

July 8, 1997

SmithKline Beecham reports novel hemoregulatory compounds

July 8, 1997

Phase I results reported for Cortecs' oral insulin

July 7, 1997

Proteoglycan synthesis increased by rhBMP-2

July 7, 1997

SmithKline Beecham and Nycomed disclose hemoregulatory compounds

July 7, 1997

Pharmacia & Upjohn discloses agents for diabetes

July 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...